cNs

Given my involvement through Harris & Harris Group, Inc., in nanotechnology, including investments in companies developing cancer therapeutics; my wife's and my long-standing philanthropic support for basic research on cancer; and my recent cancer diagnosis: I am gratified that the David H. Koch Institute for Integrative Cancer Research at MIT has established the Center for Nanotechnology Science (cNs). 

To quote from cNs literature: "Many grand challenges of addressing cancer, from detecting a few early malignant cells among billions of healthy cells, to delivering potent drugs to late-stage tumors without harming other tissue, require new approaches that target the miniscule components of cells-- DNA, RNA, proteins-- and their chemical signals and pathways. Nanotechnology, the development and engineering of devices so small that they are measured on a molecular scale, is on the brink of enabling such approaches."

Godspeed.